VAERS reports by lot

GSK DTaP/Tdap lot TF422: VAERS reports

23 VAERS reports list lot TF422 as a GSK DTaP/Tdap vaccine, received between 2017-12-26 and 2020-04-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
9%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1723%
General / Systemic (non-local)1318%
Neurological1115%
Cardiac / Cardiovascular811%
Dermatological (non-injection-site)79%
Musculoskeletal68%
Allergic / Anaphylactic45%
Respiratory45%
Gastrointestinal34%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
Tennessee3
California2
Maryland1
Georgia1
Wisconsin1
Maine1
Mississippi1
New York1
Oregon1
Arizona1
Utah1

Reports by month received

2017-121
2018-012
2018-025
2018-033
2018-043
2018-053
2018-062
2018-071
2018-101
2019-011
2020-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.